Hologic, Inc. (HOLX) Shares Sold by Earnest Partners LLC

Share on StockTwits

Earnest Partners LLC lowered its stake in shares of Hologic, Inc. (NASDAQ:HOLX) by 3.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 175,060 shares of the medical equipment provider’s stock after selling 6,152 shares during the period. Earnest Partners LLC owned about 0.06% of Hologic worth $6,959,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in HOLX. Commerzbank Aktiengesellschaft FI purchased a new stake in Hologic during the first quarter worth about $328,000. SG Americas Securities LLC raised its position in Hologic by 199.6% during the first quarter. SG Americas Securities LLC now owns 54,341 shares of the medical equipment provider’s stock worth $2,030,000 after acquiring an additional 36,201 shares during the last quarter. D.A. Davidson & CO. acquired a new position in Hologic during the first quarter worth about $242,000. State of Wisconsin Investment Board raised its position in Hologic by 25.3% during the first quarter. State of Wisconsin Investment Board now owns 354,455 shares of the medical equipment provider’s stock worth $13,242,000 after acquiring an additional 71,461 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. raised its position in Hologic by 7.1% during the first quarter. Schwab Charles Investment Management Inc. now owns 1,127,294 shares of the medical equipment provider’s stock worth $42,116,000 after acquiring an additional 74,771 shares during the last quarter. 98.66% of the stock is currently owned by hedge funds and other institutional investors.

NASDAQ:HOLX opened at $38.74 on Friday. The company has a quick ratio of 0.99, a current ratio of 1.29 and a debt-to-equity ratio of 1.12. The company has a market capitalization of $10.62 billion, a PE ratio of 18.07, a PEG ratio of 1.78 and a beta of 0.65. Hologic, Inc. has a 1-year low of $35.10 and a 1-year high of $45.09.

Hologic (NASDAQ:HOLX) last posted its quarterly earnings data on Tuesday, July 31st. The medical equipment provider reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.56 by $0.02. The business had revenue of $824.00 million during the quarter, compared to analyst estimates of $800.14 million. Hologic had a negative net margin of 2.47% and a positive return on equity of 22.18%. research analysts anticipate that Hologic, Inc. will post 2.24 earnings per share for the current fiscal year.

HOLX has been the subject of a number of research reports. BidaskClub cut shares of Hologic from a “hold” rating to a “sell” rating in a research report on Thursday, August 16th. Bank of America lifted their target price on shares of Hologic from $44.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, August 1st. Cowen restated a “buy” rating and set a $45.00 target price on shares of Hologic in a research report on Wednesday, August 1st. TheStreet upgraded shares of Hologic from a “c” rating to a “b” rating in a research report on Tuesday, July 31st. Finally, Zacks Investment Research cut shares of Hologic from a “hold” rating to a “sell” rating in a research report on Tuesday, July 3rd. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and eight have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $44.87.

About Hologic

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.

Featured Story: What kind of dividend yield to CEF’s pay?

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply